CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Dingli Technology Development (Group) Co.Ltd Company Snapshot
Shanghai Dingli Technology Development (Group) Co.Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Dingli Technology Development (Group) Co.Ltd with three other companies in this sector in China: 3sbio Inc (2015 sales of 1.67 billion Chinese Renmimbi [US$242.45 million] of which 100% was Pharmaceutical), Mayinglong Pharmaceutical Group Co Ltd (1.78 billion Chinese Renmimbi [US$258.33 million] of which 47% was Pharmaceutical Circulation), and SSY Group Ltd (1.80 billion Chinese Renmimbi [US$261.18 million] of which 98% was Intravenous Infusion Solution and Others).

Sales Analysis. During the year ended December of 2015, sales at Shanghai Dingli Technology Development (Group) Co.Ltd were 1.71 billion Chinese Renmimbi (US$248.47 million). This is an increase of 36.1% versus 2014, when the company's sales were 1.26 billion Chinese Renmimbi. Sales of Minerals saw an increase that was more than double the company's growth rate: sales were up 513.6% in 2015, from 232.91 million Chinese Renmimbi to 1.43 billion Chinese Renmimbi. Shanghai Dingli Technology Development (Group) Co.Ltd also saw significant increases in sales in Industrial - Rubber (up 167.6% to 24.25 million Chinese Renmimbi) . Not all segments of Shanghai Dingli Technology Development (Group) Co.Ltd experienced an increase in sales in 2015: sales of Other Operations fell 93.3% to 6.25 million Chinese Renmimbi. Shanghai Dingli Technology Development (Group) Co.Ltd also experienced decreases in sales in Farm Machinery (down 31.9% to 153.74 million Chinese Renmimbi) and Medicine (down 87.6% to 70.14 million Chinese Renmimbi) and Real Estate (down 71.0% to 33.06 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Dingli Technology Development (Group) Co.Ltd
  Stock Performance Chart for Shanghai Dingli Technology Development (Group) Co.Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/16/2017): 5.26
(Figures in Chinese Renmimbi)
1 Week -4.5%   13 Weeks -9.5%  
4 Weeks 14.6%   52 Weeks 19.1%  
 
Shanghai Dingli Technology Development (Group) Co.Ltd Key Data:
  Ticker: 600614 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,714,650,540
(Year Ending Jan 2016).
Employees: 1,684
  Currency: Chinese Renmimbi Market Cap: 9,217,065,973
  Fiscal Yr Ends: December Shares Outstanding: 1,752,773,758
  Share Type: A Gu Closely Held Shares: 691,332,195
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.